Experimental Pediatric Ulcerative Colitis Drug Picks Up Orphan Drug Status
News, Ulcerative colitis
AvaxiaBiologics,Inc. recently announced that the US Food and Drug Administration (FDA) granted their lead experimental drug AVX-470 Orphan Drug Designation for the treatment of pediatric ulcerative colitis. The news comes after the company previously announced the results ... Read more